15-12G 1 f15_010225.htm FORM 15-12G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER

SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION

OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934.

__________________________

Commission File Number: 001-13738

__________________________

PSYCHEMEDICS CORPORATION

(Exact name of registrant as specified in its charter)

__________________________

5220 Spring Valley Road, Suite 230

Dallas, Texas
(800) 527-7424

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

__________________________

Common Stock, par value $0.005 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

	Rule 12g-4(a)(1)	☐
	Rule 12g-4(a)(2)	☐
	Rule 12h-3(b)(1)(i)	☐
	Rule 12h-3(b)(1)(ii)	☐
	Rule 15d-6	☒
	Rule 15d-22(b)	☐

Approximate number of holders of record as of the certification or notice date: 47.

Pursuant to the requirements of the Securities Exchange Act of 1934, Psychemedics Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: January 2, 2025


	PSYCHEMEDICS CORPORATION

	By:	/s/ Brian Hullinger
		Name: Brian Hullinger
		Title: President and Chief Executive Officer

SEC Form 15-12G filed by Psychemedics Corporation